Connection

Jesús Rodríguez-Baño to Escherichia coli Infections

This is a "connection" page, showing publications Jesús Rodríguez-Baño has written about Escherichia coli Infections.
  1. Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence. Antimicrob Resist Infect Control. 2018; 7:135.
    View in: PubMed
    Score: 0.568
  2. Population pharmacokinetics and pharmacodynamics of fosfomycin in non-critically ill patients with bacteremic urinary infection caused by multidrug-resistant Escherichia coli. Clin Microbiol Infect. 2018 Nov; 24(11):1177-1183.
    View in: PubMed
    Score: 0.545
  3. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes. Int J Antimicrob Agents. 2017 Apr; 49(4):498-502.
    View in: PubMed
    Score: 0.505
  4. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis. 2006 Dec 01; 43(11):1407-14.
    View in: PubMed
    Score: 0.246
  5. Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients. Clin Microbiol Infect. 2018 Jun; 24(6):618-623.
    View in: PubMed
    Score: 0.131
  6. Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev. 2016 07 01; 40(4):437-463.
    View in: PubMed
    Score: 0.120
  7. MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae. J Antimicrob Chemother. 2017 05 01; 72(5):1478-1487.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.